Clinical Trial Update: Amitriptyline and Paroxetine Treatment of Major Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating amitriptyline and paroxetine treatment for unipolar depression has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unipolar Depression

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)
• amitriptyline (amitriptyline)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Unipolar Depression | Phase 3 | Status: COMPLETED